← Back to Search

Exercise Treatment Group for Sickle Cell Disease

N/A
Waitlist Available
Led By Foluso Ogunsile, MD
Research Sponsored by Memorial Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

Study Summary

This study is evaluating whether a specific exercise program may help improve health and quality of life for individuals with sickle cell disease.

Eligible Conditions
  • Sickle Cell Disease
  • Exercise
  • Cardiovascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability will be measured
Feasibility will be measured
Tolerability will be measured

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exercise Treatment GroupExperimental Treatment1 Intervention
Exercise Sessions

Find a Location

Who is running the clinical trial?

Memorial Healthcare SystemLead Sponsor
8 Previous Clinical Trials
1,275 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,580 Previous Clinical Trials
2,275,985 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,832 Previous Clinical Trials
47,306,336 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025